Views and analysis

No overnight cure for type 1 diabetes – but closed loops offer respite

June 13, 2017

But still little progress on finding preventive treatments.

No overnight cure for type 1 diabetes – but closed loops offer respite

https://pharmaphorum.com/views-and-analysis/closed-loop-hope-t1d-management/

Hung parliament: who will pharma negotiate with on new PPRS?

June 12, 2017

Who could influence the makeup of the new PPRS?

Hung parliament: who will pharma negotiate with on new PPRS?

https://pharmaphorum.com/views-and-analysis/hung-parliament-will-pharma-negotiate-new-pprs/

Brexit life sciences ‘beauty contest’ underway

June 9, 2017

How the UK’s exit from the EU may influence pharma companies’ decisions to stay or go.

Brexit life sciences ‘beauty contest’ underway

https://pharmaphorum.com/views-and-analysis/brexit-life-sciences-beauty-contest-underway/

ADA preview: cardio data in diabetes, drug costs and healthcare reform

June 8, 2017

Invokana data could suggest cardio benefit for SGLT2 class.

ADA preview: cardio data in diabetes, drug costs and healthcare reform

https://pharmaphorum.com/views-and-analysis/ada-preview-new-cardio-data/

New UK law to control generic drug prices – implications for pharma

June 7, 2017

The aims and implications of the Health Service Medical Supplies (Costs) Act 2017.

New UK law to control generic drug prices – implications for pharma

https://pharmaphorum.com/views-and-analysis/uk-drug-pricing-legislation/

The evolving role of clinical trial data sharing

June 6, 2017

Clinical trial data sharing has massive potential for catalysing scientific innovation.

The evolving role of clinical trial data sharing

https://pharmaphorum.com/views-and-analysis/clinical-trial-data-sharing/

Novo Nordisk: survival of the fittest applies in diabetes and obesity market

June 5, 2017

Diabetes specialist Novo Nordisk is feeling the heat from increasingly price conscious US payers. It needs next generation

Novo Nordisk: survival of the fittest applies in diabetes and obesity market

https://pharmaphorum.com/views-and-analysis/novo-nordisk-survival-fittest-applies-diabetes-obesity-market/

Digital health round-up: consumer wearables are lagging

June 2, 2017

There’s a lot more to do before consumer wearables can truly make an impact.

Digital health round-up: consumer wearables are lagging

https://pharmaphorum.com/views-and-analysis/consumer-wearables-lagging/

What a dragon can teach us about ADHD

May 31, 2017

Despite being a common condition, ADHD remains fairly misunderstood.

What a dragon can teach us about ADHD

https://pharmaphorum.com/views-and-analysis/dragon-can-teach-us-adhd/

«< 2 3 4 5 6 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Views and analysis